{
    "clinical_study": {
        "@rank": "43646", 
        "arm_group": [
            {
                "arm_group_label": "Auto fecal microbitoa therapy", 
                "arm_group_type": "Experimental", 
                "description": "autologous fecal microbiota therapy"
            }, 
            {
                "arm_group_label": "Saline enema", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Saline enema"
            }
        ], 
        "brief_summary": {
            "textblock": "Ten healthy volunteers will be recruited to receive either an autologous stool transplant or\n      a saline enema to determine if autologous fecal microbiota therapy will be able to rapidly,\n      and safely, restore a patient's fecal microbiome after antimicrobial exposure."
        }, 
        "brief_title": "Autologous Fecal Therapy", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Infectious Disease of Digestive Tract", 
        "condition_browse": {
            "mesh_term": [
                "Communicable Diseases", 
                "Infection"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Healthy Adults 18-70 years of age-\n\n        Exclusion Criteria:\n\n        history of allergic reaction to beta-lactam antimicrobials; any non-topical antimicrobial\n        exposure or tube feeds as a primary source of nutrition in the past six months; pregnant\n        or risk of becoming pregnant during the study period; gastroenteritis in the last 3\n        months; incontinent of stool; prior resection or alteration of the stomach; small bowel,\n        or colon; unwillingness to receive an enema/FMT; known colonization with an MDRO;\n        anticipated change in diet or medications, or elective surgery, during the study period;\n        or a history of an intestinal disorder -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02046525", 
            "org_study_id": "201312022", 
            "secondary_id": "1U54CK000162"
        }, 
        "intervention": {
            "arm_group_label": "Auto fecal microbitoa therapy", 
            "intervention_name": "Autologous fecal microbiota therapy", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Fecal microbiota therapy", 
        "lastchanged_date": "April 30, 2014", 
        "location": {
            "contact": {
                "email": "sseiler@wustl.edu", 
                "last_name": "Sondra Seiler", 
                "phone": "314-454-8246"
            }, 
            "facility": {
                "address": {
                    "city": "St. Louis", 
                    "country": "United States", 
                    "state": "Missouri", 
                    "zip": "63110"
                }, 
                "name": "Washington University in St. Louis"
            }, 
            "investigator": {
                "last_name": "Erik Dubberke, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Restoration of the Fecal Microbiome After Antimicrobial Exposure With Autologous Fecal Flora Restoration Therapy", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "microbial community composition (taxa that are present) and structure (abundance of taxa)", 
            "measure": "microbiome composition", 
            "safety_issue": "No", 
            "time_frame": "90 days after enrollment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02046525"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Washington University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Washington University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}